Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Opioids Market Expected to Be in 2029?

The size of the opioids market has seen a slight increase in recent years. The market will witness growth from a size of $23.54 billion in 2024 to a value of $23.98 billion in 2025, indicating a compound annual growth rate (CAGR) of 1.9%. The rise during the historical period is due to factors such as pain management, surgery procedures, provision of palliative care, and the regulatory landscape.

The market size of opioids is forecasted to experience consistent expansion in the upcoming years, reaching “$27.25 billion by 2029 with a compound annual growth rate (CAGR) of 3.3%.” This projected growth during the specified period can be associated with factors like non-cancer pain indications, changes in regulations, the rise of telemedicine and remote prescribing, along with chronic pain management. Noteworthy trend predictions within this period encompass strategies that spare opioid usage, medication-assisted treatment (MAT), risk mitigation measures, and initiatives in public health.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

What Are The Contributors To Demand In The Opioids Market?

The escalation in the number of surgical operations is predicted to bolster the expansion of the opioids market. Surgical operations are classified as therapeutic procedures that necessitate the use of tools to make an incision, typically carried out in an operating theater, and regularly requiring anesthetics or respiratory support. Opioids are utilized during surgical operations to manage pain and serve as supplements to anesthesia or as the chief anesthetic agents. As an illustration, the Organization for Economic Co-operation and Development, an intergovernmental organization based in France, in August 2023 reported an 8.4% increase in the total count of cataract surgeries in the Czech Republic rising from 131,612 surgeries in 2021 to 142,670 surgeries in 2022. Additionally, the total count of laparoscopic repairs of inguinal hernia surgeries in Turkey swelled by 35.2%, up from 18,739 in 2021 to 25,348 in 2022. Consequently, the augmented number of surgical operations is projected to stimulate the opioid market.

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

What Upcoming Trends Are Expected To Impact The Opioids Market Globally?

Predominant companies in the opioid market are concentrating on creating innovative drug solutions to bolster their standing in the industry. The introduction of novel medications can have a significant impact on treating illnesses and advancing healthcare and scientific understanding. For instance, in May 2023, the US Food and Drug Administration granted an authorization to Braeburn Pharmaceuticals Inc., a notable American firm specializing in opioid addiction treatments, for their product Brixadi (buprenorphine) – an extended-release injectable designed for subcutaneous use (underneath the skin), aimed at treating moderate to severe opioid use disorder (OUD). It stands out as the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, and the first buprenorphine injectable using FluidCrystal Injection Depot Technology. It’s noteworthy that patients already on oral buprenorphine-based medication can be seamlessly transitioned to equivalent doses of Brixadi, provided they adhere to prescription guidelines.

Who Are The Top-Ranked Companies In The Opioids Market Today?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

How Is Opioids Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model